Drug Manufacturers - General | Healthcare
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, upper respiratory, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. It also produces a range of solid oral dosage forms, including tablets and hard gelatin capsules; soft gels; essential oils; ointments; and creams and liquids, as well as prescription drugs. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Market Cap
116850434048
Current Price
255.0
52 Week Range
171.0 - 358.7
Previous Close
254.55
Open
255.0
Industry
Drug Manufacturers - General
Sector
Healthcare
Address
Grandeur, 11th Floor Veera Desai Extension Road Oshiwara, Andheri (West), Mumbai, 400053, India
Phone
+91-22400-12000
Fax
+91-22400-12011
Website
https://marksanspharma.com
Day Low
251.35
Day High
255.4
Dividend Yield
0.23
PE Ratio
30.357143
Earnings Per Share
8.4
Beta
1.384
EBITDA
5286369792
Book Value
54.49
EPS
10.75
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Mark B. Saldanha | Non-Independent Executive Chairman & MD | 52 | 1972 |
Mr. Jitendra M. Sharma | Chief Financial Officer | 55 | 1969 |
Mr. Vishal Bhargava | Director Operations | 54 | 1970 |
Mr. Harshavardhan Panigrahi | Company Secretary, Manager of Legal & Compliance Officer | - | - |
Ms. Sandra Saldanha | Whole-Time Executive Non Independent Director | 53 | 1971 |
Mr. Varddhman Vikramaditya Jain | Whole-Time Executive Non Independent Director | 54 | 1970 |
Mr. Sunil K. Rane | Senior Vice President of QC | 55 | 1969 |
Mr. David Mohammed | Managing Director of Australia Operations | - | - |
Mr. Sathish Kumar | Managing Director of UK Operations | - | - |
Mr. Anjani Kumar | Chief Operating Officer of US Operations | 64 | 1960 |
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.